Document is current
Any future updates will be listed below
-
Authors
Datta, Alexandre N.
Bürki, Sarah E.
-
Funding
Funding for this research was provided by:
University of Basel
- License Information
-
More Information
Article History
Accepted: 24 September 2024
First Online: 30 October 2024
Declarations
:
: A.N. Datta has consultant activities for Idorsia, Neurocrine, Epilog, Takeda, and Biocodex and advisory board activities for Idorsia, Eisai, Jazz Pharmaceuticals, UCB, Angelini, and Neuraxpharm, but no conflicts of interest for this manuscript. S.E. Bürki declares that there are no competing interests.
: This article does not contain any studies with human participants or animals performed by any of the authors.
